HEPATITIS A VACCINE
A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation w...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
28.11.1995
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!